Joseph F. Goldberg, MD

Consensus Statement

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

March 25, 2015

Joseph R. Calabrese, Terence A. Ketter, Joseph F. Goldberg, et al

Commentary

Efficacy of Varenicline for Smoking Cessation in Bipolar Disorder

July 25, 2014

Joseph F. Goldberg

ASCP Corner

Monoamine Oxidase Inhibitors Revisited: What You Should Know

February 15, 2013

Michael E. Thase, Joseph F. Goldberg

Article

Clinician-Rated Versus Self-Rated Screening for Bipolar Disorder Among Inpatients With Mood Symptoms and Substance Misuse

December 15, 2012

Joseph F. Goldberg, Amir Garakani, Sigurd H. Ackerman

Case Report

A Case of Akathisia After Switching From Branded to Generic High-Dose Olanzapine

April 15, 2012

Joseph F. Goldberg

Commentary

Lowering the Diagnostic Threshold for Bipolar Disorder: The Wrong Stuff?

April 15, 2012

Joseph F. Goldberg

Letter to the Editor

Antidepressant Use and Risk for Suicide Attempts in Bipolar Disorder

December 15, 2011

Joseph F. Goldberg

Original Research

Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder

September 7, 2010

Joseph R. Calabrese, Michael E. Thase, Terence A. Ketter, et al

Commentary

The Role of Divalproex Plus Olanzapine in Outpatient Mixed-Episode Bipolar I Disorder

November 15, 2009

Joseph F. Goldberg

Letter to the Editor

Reply to How Should Research Productivity Be Assessed in Early Career Psychiatric Researchers? Research Funding Versus Scientific Productivity

September 15, 2009

Joseph F. Goldberg

Original Research

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo

August 11, 2009

Joseph R. Calabrese, Terence A. Ketter, Mark A. Frye, et al

Original Research

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD

February 10, 2009

Michael E. Thase, Terence A. Ketter, Gary S. Sachs, et al

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

Efficacy of Varenicline for Smoking Cessation in Bipolar Disorder

Monoamine Oxidase Inhibitors Revisited: What You Should Know

Clinician-Rated Versus Self-Rated Screening for Bipolar Disorder Among Inpatients With Mood Symptoms and Substance Misuse

A Case of Akathisia After Switching From Branded to Generic High-Dose Olanzapine

Lowering the Diagnostic Threshold for Bipolar Disorder: The Wrong Stuff?

Antidepressant Use and Risk for Suicide Attempts in Bipolar Disorder

Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder

The Role of Divalproex Plus Olanzapine in Outpatient Mixed-Episode Bipolar I Disorder

Reply to How Should Research Productivity Be Assessed in Early Career Psychiatric Researchers? Research Funding Versus Scientific Productivity

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD

ELSEWHERE:

FOLLOW US:

Joseph F. Goldberg, MD

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

Efficacy of Varenicline for Smoking Cessation in Bipolar Disorder

Monoamine Oxidase Inhibitors Revisited: What You Should Know

Clinician-Rated Versus Self-Rated Screening for Bipolar Disorder Among Inpatients With Mood Symptoms and Substance Misuse

A Case of Akathisia After Switching From Branded to Generic High-Dose Olanzapine

Lowering the Diagnostic Threshold for Bipolar Disorder: The Wrong Stuff?

Antidepressant Use and Risk for Suicide Attempts in Bipolar Disorder

Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder

The Role of Divalproex Plus Olanzapine in Outpatient Mixed-Episode Bipolar I Disorder

Reply to How Should Research Productivity Be Assessed in Early Career Psychiatric Researchers? Research Funding Versus Scientific Productivity

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles